NewslettersESC & iPSC News A Pluripotent Road to Immunoengineering By Noshin Noorjahan - April 5, 2023 0 The variability, time commitment, and cost of engineering chimeric antigen receptor-T cells limit their application. hPSCs could provide an off-the-shelf, cheaper, and scalable solution. [Nature Reviews Bioengineering] Abstract